NeuroPace (NPCE) Other financing activities (2020 - 2026)

NeuroPace's (NPCE) quarterly Other financing activities came in at $10000.0 in Q1 2026, down 97.4% year-on-year from $385000.0 in Q1 2025, and down 98.62% quarter-over-quarter from $723000.0 in Q4 2025.

NeuroPace (NPCE) Other financing activities (2020 - 2026) Analysis & Trends

NeuroPace's Other financing activities history runs 7 years deep, the most recent figure standing at $10000.0 for Q1 2026.

  • On a quarterly basis, Other financing activities fell 97.4% year-over-year to $10000.0 in Q1 2026; TTM through Mar 2026 was $1.5 million, a 5.96% decrease from a year earlier, with the FY2025 full-year figure at $1.9 million, down 2.9% from the prior year.
  • Other financing activities eased to $10000.0 in Q1 2026 per NPCE's latest filing, from $723000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $766000.0 in Q2 2025 and bottomed at -$683000.0 in Q4 2022.
  • The 5-year median for Other financing activities is $315000.0 (2023), against an average of $288687.5.
  • Across the five-year window, Other financing activities tumbled 100.63% in 2022 and soared 72000.0% in 2024, its largest moves.
  • Year by year, Other financing activities stood at -$683000.0 in 2022, then soared by 180.38% to $549000.0 in 2023, then climbed by 8.38% to $595000.0 in 2024, then increased by 21.51% to $723000.0 in 2025, then tumbled by 98.62% to $10000.0 in 2026.
  • Per Business Quant, the three latest NPCE Other financing activities figures stand at $10000.0 (Q1 2026), $723000.0 (Q4 2025), and $1000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 NeuroPace 494.96 Mn 440.98 Mn 18.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 10,000.00
Mar 31, 2026 10,000.00
Dec 31, 2025 723,000.00
Dec 31, 2025 723,000.00
Sep 30, 2025 1,000.00
Sep 30, 2025 1,000.00
Jun 30, 2025 766,000.00
Jun 30, 2025 766,000.00
Mar 31, 2025 385,000.00
Mar 31, 2025 385,000.00
Dec 31, 2024 595,000.00
Dec 31, 2024 595,000.00
Sep 30, 2024 34,000.00
Sep 30, 2024 34,000.00
Jun 30, 2024 581,000.00
Jun 30, 2024 581,000.00
Mar 31, 2024 721,000.00
Mar 31, 2024 721,000.00
Dec 31, 2023 549,000.00
Dec 31, 2023 549,000.00